Helius Medical Technologies Inc.
Helius Medical Technologies Inc.
Helius Medical Technologies Inc., through its wholly-owned subsidiary NeuroHabilitation Corporation, is dedicated to developing products that treat neurological symptoms caused by disease or trauma. The Company's Portable Neuro-modulation Stimulator ("PoNS") device that shows anecdotal promise is making it through the clinical trial process for the treatment of balance disorder in patients who suffered a traumatic brain injury ("TBI") or from neurological disease.
Helius Medical Technologies Inc. (HSM)
SEDAR Information
Information d'entreprise
Capitalisation
Communiqués de presse
Bulletins
2016-0408 - Delist - Helius Medical Technologies Inc.(HSM)
Les actions ordinaires de Helius Medical Technologies Inc. seront radiées à la fermeture des marchés aujourd'hui, 18 avril 2016.
Helius Medical Technologies Inc. continuera de commerce à la bourse de Toronto
Date : Clôture du marché, 18 avril 2016
Symbole : HSM
Si vous avez des questions ou désirez des renseignements supplémentaires, ou à supprimer de la mailing liste, veuillez contacter inscriptions à (416) 367-7340 ou par courriel : listings@thecse.com
